1. Boscá MM, Añón R, Mayordomo E, Villagrasa R, Balza N, Amorós C, et al. Methotrexate induced sprue-like syndrome. World J Gastroenterol. 2008;14(45):7009–11.
2. Erspamer V, Tstinini A. Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J Pharm Pharmacol. 1959;11:618–23.
3. Yu PL, Fujimura M, Okumiya K, Kinoshita M, Hasegawa H, Fujimiya M. Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts. J Comp Neurol. 1999;411(4):654–65.
4. Takano Y, Machida T, Obara Y, Hirano M, Kudo S, Takagi M, et al. Methotrexate causes a change in intestinal 5-hydroxytryptamine metabolism in rats. Eur J Pharmacol. 2014;740:496–503.
5. Takano Y, Hirano M, Machida T, Obara Y, Hamaue N, Fujita K, et al. Nitric oxide plays a critical role in methotrexate-induced hyperplasia of enterochromaffin cells containing 5-hydroxytryptamine in rat small intestine. J Pharmacol Sci. 2019;141(1):32–40.